Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nipah virus antigens are viral proteins, most notably the surface glycoproteins G (attachment protein) and F (fusion protein), and the nucleocapsid protein N. These antigens are key targets for diagnostic assays, vaccine development, and therapeutic antibody design. The G glycoprotein mediates attachment to host cell receptors (ephrin-B2 and ephrin-B3), while the F glycoprotein facilitates membrane fusion. The N protein is an internal structural protein used in diagnostics due to its high abundance. These antigens elicit immune responses, particularly neutralizing antibodies against G and F, which are critical for protection against Nipah virus infection.
Neutralization of viral entry, inhibition of viral replication
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nipah Virus Antigen (NiV Antigen).